Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy

✍ Scribed by Cora N. Sternberg; Fabio Calabrò; Giorgio Pizzocaro; Luca Marini; Sylvia Schnetzer; Avishay Sella

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 66 KB
• Volume: 92
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(20011215)92:12<2993::aid-cncr10108>3.0.co;2-2